Casey Logan
Corporate Officer/Principal at TRAVERE THERAPEUTICS, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Scott Brown | M | 43 | 9 years | |
Eric Dube | M | 51 | 5 years | |
Patricia Bitar | F | 65 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 5 years |
Chris Cline | M | 40 | 10 years | |
Jeffrey Meckler | M | 57 | 10 years | |
Gary Lyons | M | 73 | 10 years | |
Robert C. Coates | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 15 years |
Martin Mattingly | M | 66 | 10 years | |
John Orwin | M | 59 | 7 years | |
Sandra Calvin | F | 59 | 10 years | |
Sandra E. Poole | F | 60 | 5 years | |
Travis Coy | M | 43 | 21 years | |
Elizabeth Reed | F | 53 | 7 years | |
Ron Squarer | M | 57 | 7 years | |
Roy Baynes | M | 69 | 8 years | |
Tim Coughlin | M | 57 | 9 years | |
Stephen Worland | M | 66 | 9 years | |
Ruth Williams-Brinkley | F | 72 | 3 years | |
Mark Joseph Cantwell | M | 54 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
Jon Fyrwald | M | 63 | 19 years | |
Suzanne Bruhn | M | 60 | 4 years | |
William LaRue | M | 73 | 10 years | |
Gregory Brown | M | 70 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 4 years |
John Poulos | M | 70 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | 4 years |
Bill Rote | M | 61 | 7 years | |
Christopher J. Pagano | M | 60 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
Peter Heerma | M | 53 | 5 years | |
Edgardo Hernandez | M | - | 19 years | |
Steven Whitley | M | - |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | - |
Jula Inrig | M | 49 | 2 years | |
Angela Giannantonio | F | - | - | |
Charlotte Smith | F | - | - | |
Nivi Nehra | F | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Aselage | M | 73 | 10 years | |
Katherine Bowdish | M | 67 |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | - |
Ellen Marram | F | 77 | 17 years | |
Ronak H. Shah | M | - | 3 years | |
Paul Grayson | M | - |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | 12 years |
Pedro Granadillo | M | 77 | 34 years | |
Hironori Hozoji | M | 63 | 4 years | |
Kenji Harada | M | 64 | 4 years | |
Laura Clague | F | 64 | 8 years | |
Michael Ackermann | M | - | 2 years | |
Martin Feldstein | M | 84 | 10 years | |
Anat Ashkenazi | F | 51 | 23 years | |
Derica Rice | M | 59 | 14 years | |
John Kozarich | M | 74 | 5 years | |
Jeffrey Henderson | M | 59 | 7 years | |
Webster Dunbar | M | 62 | 5 years | |
Paul Walker | M | 49 | - | |
Rolf K. Hoffmann | M | 64 | 17 years | |
KULDEEP NEOTE | M | - | 17 years | |
Alfred Scheidegger | M | 67 | 2 years | |
James T. Glover | M | 74 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | 3 years |
Armen Shanafelt | M | 64 | 7 years | |
Charl van Zyl | M | 57 | 9 years | |
Cezary Nadecki | M | - | 2 years | |
Robert Baughman | M | - | - | |
Carlos Paya | M | 65 | 7 years | |
Andrea Cranfill | F | - | 1 years | |
Scott M. Stiffler | M | 54 | 7 years | |
Candace Brandt | F | - | 3 years | |
Bing Li | M | 55 | 7 years | |
James Anderson | M | 74 | 4 years | |
Carl L. McMillian | M | 60 | - | |
Michael Overdorf | M | 54 | 19 years | |
Yao Chang Xu | M | 67 | 13 years | |
Adam Houghton | M | - | 10 years | |
Julie Gilmore | M | - | - | |
Richard Buckley | M | 55 | 7 years | |
Jed Kay | M | - | 16 years | |
Neal Fowler | M | 62 | 13 years | |
James Posada | M | - | 4 years | |
Lori Queisser | F | 63 | 5 years | |
Charles E. Golden | M | 77 | 10 years | |
Ford R. Lynch | M | 77 | 11 years | |
James A. Harper | M | 77 | 10 years | |
Gary D. Tollefson | M | 72 | 13 years | |
Charles Schalliol | M | 76 | 25 years | |
Richard DiMarchi | M | 71 | 11 years | |
Pierre V. Trân | M | 64 | 12 years | |
Franklin P. Bymaster | M | 78 | - | |
James C. Lancaster | M | 77 | 6 years | |
Freda Lewis-Hall | M | 69 | 8 years | |
Steven C. Beering | M | 91 | - | |
J. Michael Cook | M | 81 | 4 years | |
John Edward Victor Rose | M | 72 | - | |
Martin F. Haslanger | M | - | 9 years | |
David A. Broecker | M | 63 | 16 years | |
Brett L. Schmidli | M | 72 | 10 years | |
Morris Z. Rosenberg | M | 64 | 3 years | |
Thomas Verhoeven | M | - | - | |
Vanessah Ng | F | - | - | |
Joseph Zakrzewski | M | 60 | 16 years | |
Alan Breier | M | - | - | |
Arnold A. Pinkston | M | 65 | 11 years | |
David Thompson | M | 76 | 34 years | |
Homer Pearce | M | 71 | 27 years | |
Jerome H. Fleisch | M | - | 27 years | |
Mark Andersen | M | 53 | 11 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Casey Logan
- Personal Network